185 related articles for article (PubMed ID: 9600076)
1. Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.
Gomez DE; Tejera AM; Olivero OA
Biochem Biophys Res Commun; 1998 May; 246(1):107-10. PubMed ID: 9600076
[TBL] [Abstract][Full Text] [Related]
2. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
3. [Azidothymidine, blocking telomerase functioning, shortens telomeric repeats in transformed human cells].
Egorov EE; Akhmalisheva AKh; Smirnova IuB; Shinkarev DB; Chernov DN; Zelenin AV; Kraevskiĭ AA
Genetika; 1997 Oct; 33(10):1444-6. PubMed ID: 9445812
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
5. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
6. Reduction of telomeric signals in murine melanoma and human breast cancer cell lines treated with 3'-azido-2'-3'-dideoxythymidine.
Multani AS; Furlong C; Pathak S
Int J Oncol; 1998 Nov; 13(5):923-5. PubMed ID: 9772280
[TBL] [Abstract][Full Text] [Related]
7. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.
Strahl C; Blackburn EH
Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329
[TBL] [Abstract][Full Text] [Related]
8. Telomeric 3'-overhang length is associated with the size of telomeres.
Rahman R; Forsyth NR; Cui W
Exp Gerontol; 2008 Apr; 43(4):258-65. PubMed ID: 18280685
[TBL] [Abstract][Full Text] [Related]
9. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
[TBL] [Abstract][Full Text] [Related]
10. Telomere maintenance by recombination in human cells.
Dunham MA; Neumann AA; Fasching CL; Reddel RR
Nat Genet; 2000 Dec; 26(4):447-50. PubMed ID: 11101843
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization effect of zidovudine on human malignant glioma cells.
Zhou FX; Liao ZK; Dai J; Xiong J; Xie CH; Luo ZG; Liu SQ; Zhou YF
Biochem Biophys Res Commun; 2007 Mar; 354(2):351-6. PubMed ID: 17223082
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
Melana SM; Holland JF; Pogo BG
Clin Cancer Res; 1998 Mar; 4(3):693-6. PubMed ID: 9533539
[TBL] [Abstract][Full Text] [Related]
13. Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines.
Tokutake Y; Matsumoto T; Watanabe T; Maeda S; Tahara H; Sakamoto S; Niida H; Sugimoto M; Ide T; Furuichi Y
Biochem Biophys Res Commun; 1998 Jun; 247(3):765-72. PubMed ID: 9647768
[TBL] [Abstract][Full Text] [Related]
14. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
15. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Goodwin EC; DiMaio D
Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
[TBL] [Abstract][Full Text] [Related]
16. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
17. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
Bernardo ME; Zaffaroni N; Novara F; Cometa AM; Avanzini MA; Moretta A; Montagna D; Maccario R; Villa R; Daidone MG; Zuffardi O; Locatelli F
Cancer Res; 2007 Oct; 67(19):9142-9. PubMed ID: 17909019
[TBL] [Abstract][Full Text] [Related]
18. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
19. Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress.
Yokoo S; Furumoto K; Hiyama E; Miwa N
J Cell Biochem; 2004 Oct; 93(3):588-97. PubMed ID: 15378602
[TBL] [Abstract][Full Text] [Related]
20. Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.
Cerone MA; Londoño-Vallejo JA; Autexier C
Oncogene; 2006 Nov; 25(56):7411-20. PubMed ID: 16767163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
